Precision Allergy: Separate Allergies to Male and Female Dogs

November 14, 2022 updated by: Copenhagen Studies on Asthma in Childhood

A new male-specific dog-allergen-component has been found (Can f 5) which indicates possible differences in allergic reactions to male and female dogs. This has not yet been tested in real life.

The aim is to test if sensitization only to the male-dog specific allergen-component, Can f 5, results in a positive skin prick test (SPT) to male dog extract and not female dog extract. In addition, the investigators want to investigate if allergic symptoms only occur when exposed to the male dog extract by conjunctival provocation.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Copenhagen
      • Gentofte, Copenhagen, Denmark, 2820
        • Copsac, DBAC

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Participants in the COPSAC 2000 cohort
  • Positive component test (>0.3 ISU) to Can f 1, Can f 2, Can f 3 or Can f 5

Exclusion Criteria:

  • Uncontrolled asthma
  • Eye-surgery within the past 6 months
  • Antihistamine allergy
  • and others

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Male dog
Male dog extract used for skin prick test and conjunctival provocation
Male dog extract
Active Comparator: Female dog
Female dog extract used for skin prick test and conjunctival provocation
Female dog extract

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Male vs. female dog SPT in Can f 5 mono sensitized patients
Time Frame: 6 months
In the patients that have a positive SPT (> 2mm) to dog and are monosensitized to the Can f 5 component, the investigatiors want to compare the reaction to SPT (pos/neg) to male vs. female dog extract in the same patient using logistic regression analysis with mixed effects to account for repeated measures.
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Male vs. female dog conjunctival provocation in Can f 5 mono sensitized patients
Time Frame: 6 months
In the patients that have a positive SPT (> 2mm) to dog and are monosensitized to the Can f 5 component, the investigatiors want to compare the reaction to conjunctival provocation (positive/negative) to male vs. female dog extract in the same patient using logistic regression analysis with mixed effects to account for repeated measures.
6 months
Male vs. female dog SPT in dog poly sensitized patients
Time Frame: 6 months
In the patients that have a positive SPT (> 2mm) to dog and are sensitized to the Can f 1, 2 and/or 3 component, the investigatiors want to compare the reaction to SPT (pos/neg) to male vs. female dog extract in the same patient using logistic regression analysis with mixed effects to account for repeated measures.
6 months
Male vs. female dog conjunctival provocation in dog poly sensitized patients
Time Frame: 6 months
In the patients that have a positive SPT (> 2mm) to dog and are sensitized to the Can f 1, 2 and/or 3 component, the investigatiors want to compare the reaction to conjunctival provocation (pos/neg) to male vs. female dog extract in the same patient using logistic regression analysis with mixed effects to account for repeated measures.
6 months
Can f 5 vs. SPT size
Time Frame: 6 months
To investigate the correlation between specific Immunoglobulin E (sIgE) level to the Can f 5 component and the SPT wheal size to the male dog extract using a general linear model.
6 months
Can f 5 vs. conjunctival provocation
Time Frame: 6 months
To investigate the correlation between sIgE level to the Can f 5 component and the threshold of reaction to the male dog extract at the conjunctival provocation, using a general linear model.
6 months
SPT vs. conjunctival provocation
Time Frame: 6 months
To investigate the correlation between SPT wheal size to the male dog extract and the threshold of reaction to the male dog extract at the conjunctival provocation, using a general linear model.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Klaus Bønnelykke, MD, PhD, Copenhagen Studies on Asthma in Childhood

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 24, 2017

Primary Completion (Actual)

September 1, 2017

Study Completion (Actual)

January 9, 2019

Study Registration Dates

First Submitted

March 24, 2017

First Submitted That Met QC Criteria

March 24, 2017

First Posted (Actual)

March 31, 2017

Study Record Updates

Last Update Posted (Actual)

November 15, 2022

Last Update Submitted That Met QC Criteria

November 14, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Dog allergy

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Allergy; Dander

Clinical Trials on Male dog

Subscribe